Task: Answer the multiple choice question.
Query: Which drug exhibits a -7.681% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. N#CCCn1c(SCC(=O)Nc2ccc(N3CCOCC3)cc2)nc2ccccc21
b. COc1ccc(Cn2cc(F)c(=O)n(CCC(C)C)c2=O)cc1[N+](=O)[O-]
Answer: a. N#CCCn1c(SCC(=O)Nc2ccc(N3CCOCC3)cc2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#CCCn1c(SCC(=O)Nc2ccc(N3CCOCC3)cc2)nc2ccccc21
N#CCCn1c(SCC(=O)Nc2ccc(N3CCOCC3)cc2)nc2ccccc21
2-[1-(2-cyanoethyl)benzimidazol-2-yl]sulfanyl-N-(4-morpholin-4-ylphenyl)acetamide